680 related articles for article (PubMed ID: 23317655)
1. Thinner choroid and greater drusen extent in retinal angiomatous proliferation than in typical exudative age-related macular degeneration.
Kim JH; Kim JR; Kang SW; Kim SJ; Ha HS
Am J Ophthalmol; 2013 Apr; 155(4):743-9, 749.e1-2. PubMed ID: 23317655
[TBL] [Abstract][Full Text] [Related]
2. Subfoveal choroidal thickness as a potential predictor of visual outcome and treatment response after intravitreal ranibizumab injections for typical exudative age-related macular degeneration.
Kang HM; Kwon HJ; Yi JH; Lee CS; Lee SC
Am J Ophthalmol; 2014 May; 157(5):1013-21. PubMed ID: 24487050
[TBL] [Abstract][Full Text] [Related]
3. Age-related macular degeneration and risk factors for the development of choroidal neovascularisation in the fellow eye: a 3-year follow-up study.
Silva R; Cachulo ML; Fonseca P; Bernardes R; Nunes S; Vilhena N; Faria de Abreu JR
Ophthalmologica; 2011; 226(3):110-8. PubMed ID: 21822000
[TBL] [Abstract][Full Text] [Related]
4. Subfoveal choroidal thickness after ranibizumab therapy for neovascular age-related macular degeneration: 12-month results.
Yamazaki T; Koizumi H; Yamagishi T; Kinoshita S
Ophthalmology; 2012 Aug; 119(8):1621-7. PubMed ID: 22551738
[TBL] [Abstract][Full Text] [Related]
5. Subfoveal choroidal thickness in retinal angiomatous proliferation.
Yamazaki T; Koizumi H; Yamagishi T; Kinoshita S
Retina; 2014 Jul; 34(7):1316-22. PubMed ID: 24406386
[TBL] [Abstract][Full Text] [Related]
6. Subfoveal choroidal thickness changes after intravitreal ranibizumab and photodynamic therapy for retinal angiomatous proliferation.
Maruko I; Iida T; Oyamada H; Sugano Y; Saito M; Sekiryu T
Retina; 2015 Apr; 35(4):648-54. PubMed ID: 25627088
[TBL] [Abstract][Full Text] [Related]
7. Correlation between neovascular lesion type and clinical characteristics of nonneovascular fellow eyes in patients with unilateral, neovascular age-related macular degeneration.
Marsiglia M; Boddu S; Chen CY; Jung JJ; Mrejen S; Gallego-Pinazo R; Freund KB
Retina; 2015 May; 35(5):966-74. PubMed ID: 25627089
[TBL] [Abstract][Full Text] [Related]
8. Segregation of ophthalmoscopic characteristics according to choroidal thickness in patients with early age-related macular degeneration.
Switzer DW; Mendonça LS; Saito M; Zweifel SA; Spaide RF
Retina; 2012 Jul; 32(7):1265-71. PubMed ID: 22222760
[TBL] [Abstract][Full Text] [Related]
9. Small retinal haemorrhages accompanied by macular soft drusen: prevalence, and funduscopic and angiographic characteristics.
Kim JH; Lee TG; Kim JW; Kim CG; Cho SW; Han JI
Br J Ophthalmol; 2014 Aug; 98(8):1066-72. PubMed ID: 24659351
[TBL] [Abstract][Full Text] [Related]
10. Macular choroidal thickness and volume of eyes with reticular pseudodrusen using swept-source optical coherence tomography.
Ueda-Arakawa N; Ooto S; Ellabban AA; Takahashi A; Oishi A; Tamura H; Yamashiro K; Tsujikawa A; Yoshimura N
Am J Ophthalmol; 2014 May; 157(5):994-1004. PubMed ID: 24491418
[TBL] [Abstract][Full Text] [Related]
11. Genetic and clinical factors associated with reticular pseudodrusen in exudative age-related macular degeneration.
Yoneyama S; Sakurada Y; Mabuchi F; Imasawa M; Sugiyama A; Kubota T; Iijima H
Graefes Arch Clin Exp Ophthalmol; 2014 Sep; 252(9):1435-41. PubMed ID: 24595987
[TBL] [Abstract][Full Text] [Related]
12. Subfoveal Choroidal Thickness during Aflibercept Therapy for Neovascular Age-Related Macular Degeneration: Twelve-Month Results.
Koizumi H; Kano M; Yamamoto A; Saito M; Maruko I; Sekiryu T; Okada AA; Iida T
Ophthalmology; 2016 Mar; 123(3):617-24. PubMed ID: 26686967
[TBL] [Abstract][Full Text] [Related]
13. Intravitreal anti-vascular endothelial growth factor for submacular hemorrhage from choroidal neovascularization.
Kim JH; Chang YS; Kim JW; Kim CG; Yoo SJ; Cho HJ
Ophthalmology; 2014 Apr; 121(4):926-35. PubMed ID: 24342019
[TBL] [Abstract][Full Text] [Related]
14. Choroidal thickness, vascular hyperpermeability, and complement factor H in age-related macular degeneration and polypoidal choroidal vasculopathy.
Jirarattanasopa P; Ooto S; Nakata I; Tsujikawa A; Yamashiro K; Oishi A; Yoshimura N
Invest Ophthalmol Vis Sci; 2012 Jun; 53(7):3663-72. PubMed ID: 22570352
[TBL] [Abstract][Full Text] [Related]
15. Choroidal Thickness Changes in Age-Related Macular Degeneration and Polypoidal Choroidal Vasculopathy: A 12-Month Prospective Study.
Ting DS; Ng WY; Ng SR; Tan SP; Yeo IY; Mathur R; Chan CM; Tan AC; Tan GS; Wong TY; Cheung CM
Am J Ophthalmol; 2016 Apr; 164():128-36.e1. PubMed ID: 26743619
[TBL] [Abstract][Full Text] [Related]
16. Influence of age-related macular degeneration on macular thickness measurement made with fourier-domain optical coherence tomography.
Garas A; Papp A; Holló G
J Glaucoma; 2013 Mar; 22(3):195-200. PubMed ID: 22314250
[TBL] [Abstract][Full Text] [Related]
17. Imaging characteristics of neovascular pigment epithelial detachments and their response to anti-vascular endothelial growth factor therapy.
Punjabi OS; Huang J; Rodriguez L; Lyon AT; Jampol LM; Mirza RG
Br J Ophthalmol; 2013 Aug; 97(8):1024-31. PubMed ID: 23759437
[TBL] [Abstract][Full Text] [Related]
18. Comparison of macular choroidal thickness in adult onset foveomacular vitelliform dystrophy and age-related macular degeneration.
Coscas F; Puche N; Coscas G; Srour M; Français C; Glacet-Bernard A; Querques G; Souied EH
Invest Ophthalmol Vis Sci; 2014 Jan; 55(1):64-9. PubMed ID: 24282233
[TBL] [Abstract][Full Text] [Related]
19. Subfoveal Choroidal Thickness in Eyes with Neovascular Age-Related Macular Degeneration Treated with Anti-Vascular Endothelial Growth Factor Agents.
Kanadani TCM; Veloso CE; Nehemy MB
Ophthalmologica; 2018; 240(4):200-207. PubMed ID: 29768266
[TBL] [Abstract][Full Text] [Related]
20. Multimodal imaging of early stage 1 type 3 neovascularization with simultaneous eye-tracked spectral-domain optical coherence tomography and high-speed real-time angiography.
Querques G; Souied EH; Freund KB
Retina; 2013 Oct; 33(9):1881-7. PubMed ID: 23644560
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
